PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New hope for Gaucher patients

2014-01-20
(Press-News.org) Contact information: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
New hope for Gaucher patients

What causes brain damage and inflammation in severe cases of Gaucher disease? Little is known about the events that lead to brain pathology in some forms of the disease, and there is currently no treatment available – a bleak outlook for sufferers and their families. Now, scientists at the Weizmann Institute of Science have discovered a new cellular pathway implicated in Gaucher disease. Their findings, published today in Nature Medicine, may offer a new therapeutic target for the management of this disease, as well as other related disorders.

Gaucher disease is a genetic disorder most prevalent among the Ashkenazi Jewish population. It is caused by a defect in a particular enzyme needed to break down a fatty substance, or lipid, called glucocerebroside. This results in the accumulation of glucocerebroside in various cells and organs, which prevents them from working properly. There are three subtypes of the disease: The most common form – Type 1 – is characterized by, among other symptoms, swelling and enlargement of the spleen and liver and disruption in the function of these organs, along with lung and bone problems. These symptoms can also affect individuals with Types 2 and 3 Gaucher disease, but what distinguishes them from Type 1 is the neurological involvement: Type 2 – the most severe form – causes extensive brain damage and death before two years of age, while Type 3 is a more progressive form of the disease that affects the brain, with patients often living into their early teens and adulthood.

But what exactly causes such a massive loss of nerve cells in Types 2 and 3 Gaucher disease? It has recently come to light that a certain biochemical pathway, of which a protein called RIP3 is a key player, is involved in triggering the cell death and inflammatory processes that can have severe consequences in a number of diseases. Dr. Einat Vitner and M.Sc. student Ran Salomon, in the lab of Prof. Tony Futerman of the Biological Chemistry Department, wondered whether this could also be one of the missing links in the understanding of the chain of molecular events leading to brain inflammation and nerve cell death in Gaucher disease. To find out, they induced Gaucher disease in mice possessing the RIP3 protein, as well as in mice lacking RIP3. In mice lacking the RIP3 protein, they demonstrated not only a significant improvement in motor coordination and brain pathology but also improved liver and spleen function. Their lifespan was also remarkably increased from approximately 35 days to more than 170 days.

Vitner: "These results are exciting, as they suggest a plausible new target for therapeutic intervention for all types of Gaucher disease; they have the potential, in the future, to greatly improve the patients' quality of life."

Indeed, although effective enzyme replacement therapy exists in which Gaucher patients are treated with injections of an intact version of the enzyme responsible for the normal breakdown of the lipid in healthy people, the cost of the lifelong treatment is approximately $200,000 per patient per year. Moreover, the enzyme is unable to get into the brain since it cannot cross the blood-brain barrier, rendering it ineffective in treating the neurological symptoms of Types 2 and 3 Gaucher disease. Hence, more affordable and alternative treatments are urgently needed.

"If successful, the new target could be used as either a complementary or alternative therapy for Gaucher disease, and with RIP3 proving to be a 'hot' cellular pathway in various pathologies, these results may also have implications in other neurodegenerative diseases, including related diseases such as Krabbe disease, and potentially other devastating brain diseases," says Futerman.

The Children's Gaucher Research Fund

Beginning with a memorial fund in honor of their son Gregory, who lost his life to Neuronopathic Gaucher (nGD) disease at the tender age of four, Greg and Deborah Macres have grown the Children's Gaucher Research Fund into a nonprofit charity that has raised over $2 million since its inception in 1999. In this grassroots organization in California, 100% of the donations go directly to research – the administrative costs are covered by the Macreses themselves, and it is supported by parents who have lost their children to nGD. It has been instrumental in enabling research aimed at finding a cure for Types 2 and 3 Gaucher Disease, such as that carried out in the lab of Prof. Tony Futerman at the Weizmann Institute, as well as providing support to families of children who battle this disease.

Greg: "We began funding Tony in 2001 and are truly grateful for his commitment to pursuing something that very few scientists have had an interest in. His new discovery, which has major implications not only for neuronopathic Gaucher Disease, but potentially and quite remarkably for Krabbe Disease, gives us encouragement. We hope to be able to continue this journey so that one day, our goal is reached in the form of words from a physician to the anxious parents of a sick child – 'Do not worry, we have a cure'."



INFORMATION:

Prof. Anthony H. Futerman's research is supported by the Nella and Leon Benoziyo Center for Neurological Diseases, which he heads; the M.D. Moross Institute for Cancer Research; and the Carolito Stiftung. Prof. Futerman is the incumbent of the Joseph Meyerhoff Professorial Chair of Biochemistry.

The Weizmann Institute of Science in Rehovot, Israel, is one of the world's top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, the Institute is home to scientists, students, technicians and supporting staff. Institute research efforts include the search for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.

Weizmann Institute news releases are posted on the World Wide Web at http://wis-wander.weizmann.ac.il/, and are also available at http://www.eurekalert.org/



ELSE PRESS RELEASES FROM THIS DATE:

Overexpression of splicing protein in skin repair causes early changes seen in skin cancer

2014-01-20
Overexpression of splicing protein in skin repair causes early changes seen in skin cancer Cold Spring Harbor, NY – Normally, tissue injury triggers a mechanism in cells that tries to repair damaged tissue and restore the skin to a normal, or homeostatic state. Errors ...

The water cycle amplifies abrupt climate change

2014-01-20
The water cycle amplifies abrupt climate change The role of the hydrological cycle during abrupt temperature changes is of prime importance for the actual impact of climate change on the continents. In a new study published in Nature ...

Solar-power device would use heat to enhance efficiency

2014-01-20
Solar-power device would use heat to enhance efficiency New approach developed at MIT could generate power from sunlight efficiently and on demand CAMBRIDGE, Mass-- A new approach to harvesting solar energy, developed by MIT researchers, could improve ...

Distant quasar illuminates a filament of the cosmic web

2014-01-20
Distant quasar illuminates a filament of the cosmic web Astronomers capture first image of diffuse gas within the network of filaments connecting galaxies in a cosmic web Astronomers have discovered a distant quasar illuminating a vast nebula of diffuse gas, revealing ...

Get used to heat waves: Extreme El Nino events to double

2014-01-20
Get used to heat waves: Extreme El Nino events to double Rain pattern research confirms the impacts of unusuala and extreme El Nino events Extreme weather events fuelled by unusually strong El Ninos, such as the 1983 heatwave that led to the Ash Wednesday ...

Island channel could power about half of Scotland, studies show

2014-01-20
Island channel could power about half of Scotland, studies show Renewable tidal energy sufficient to power about half of Scotland could be harnessed from a single stretch of water off the north coast of the country, engineers say Renewable tidal energy sufficient ...

Ingredients in chocolate, tea and berries could guard against diabetes

2014-01-20
Ingredients in chocolate, tea and berries could guard against diabetes Eating high levels of flavonoids including anthocyanins and other compounds (found in berries, tea, and chocolate) could offer protection from type 2 diabetes - according to research ...

Milky Way may have formed 'inside-out': Gaia provides new insight into Galactic evolution

2014-01-20
Milky Way may have formed 'inside-out': Gaia provides new insight into Galactic evolution A breakthrough using data from the Gaia-ESO project has provided evidence backing up theoretically predicted divisions in the chemical composition of the stars that ...

York scientists investigate the fiber of our being

2014-01-20
York scientists investigate the fiber of our being We are all aware of the health benefits of "dietary fibre". But what is dietary fibre and how do we metabolise it? Research at the University of York's Structural Biology Laboratory, in collaboration with groups ...

Cleveland Clinic identifies mechanism in Alzheimer's-related memory loss

2014-01-20
Cleveland Clinic identifies mechanism in Alzheimer's-related memory loss Study uncovers role of Neuroligin-1 protein Sunday, Jan. 19, 2014, Cleveland: Cleveland Clinic researchers have identified a protein in the brain that plays a critical role in the memory loss seen in ...

LAST 30 PRESS RELEASES:

Anna Wuttig wins Bayer Foundation Early Excellence in Science Award

Electric vehicles outperform gasoline cars in lifetime environmental impact

Kilimanjaro has lost 75 percent of its natural plant species over the last century

Spider web “decorations” may help pinpoint location of captured prey

Ancient tombs reveal the story of Chinese history

1 in 3 university students surveyed from a Parisian suburb report being unable to access desired food, with this food insecurity associated with academic dropout

Researchers uncover oldest 3D burrow systems in Hubei's Shibantan Biota

Discovery of a new principle: chiral molecules adhere to magnets

New algorithm lets autonomous drones work together to transport heavy, changing payloads

Lehigh University team develops computational model to guide neurostimulation therapy for atrial fibrillation

Survival of the blandest: Unusual sharks face highest extinction risk

Research alert: Bioinformatics uncovers regenerative therapy for spinal cord injury

Sustainable chemistry with the help of Artificial Intelligence

Quantum jam sessions teach quantum and jamming

Health care professionals sponsored for H-1B visas in the US

Study shows increase of H1-B visa fees will most impact rural and high-poverty counties

How age affects vaccine responses and how to make them better

MAGIC: AI-assisted laser tag illuminates cancer origins

Major milestone achieved in capturing ribosome assembly

International research team decodes the pangenome of oats

A doorstop for the brain’s electrical gates

Tiny 3D printer reconstructs tissues during vocal cord surgery

New genetic marker found to predict severe gout drug reactions in US patients

Schizophrenia, bipolar, or major depressive disorder and postacute sequelae of COVID-19

Fruit flies offer new insights into how human Alzheimer’s Disease risk genes affect the brain

University of Phoenix College of Doctoral Studies releases white paper on mentoring programs to strengthen worker autonomy and competitive edge

International scientists issue State of the Climate Report, highlight mitigation strategies

“State of the climate” 2025: Earth’s vital signs worsen, science shows options for livable future

New nanomedicine wipes out leukemia in animal study

National TRAP Program targets ghostly issue with second round of coastal clean up funding

[Press-News.org] New hope for Gaucher patients